CRVO vs MTB · $28.8M cap vs P/E 12, rev $860.0M
CervoMed Inc. (CRVO) versus M&T Bank Corporation (MTB) — a side-by-side from cached financials, not a winner call.
CervoMed Inc. (CRVO) is a biotechnology company listed on US.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
Latest reported CRVO revenue for 2026-06-30 was $0. Net income was -$14.5M. CRVO currently screens at market cap $28.8M.
Latest reported MTB revenue for 2026-06-30 was $860.0M. Net income was $1.48B. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
CRVO currently screens at market cap $28.8M. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Not investment advice. Open the CRVO and MTB stock pages for the full models.
Not investment advice.